Instructors can request access to the Casebook Instructor's Guide on AccessPharmacy. Email User Services (email@example.com) for more information.
After completing this case study, the reader should be able to:
Identify the importance of regular eye examinations and the early diagnosis of glaucoma.
List the risk factors for developing open-angle glaucoma.
Select and recommend agents from different pharmacologic classes when indicated and provide the rationale for drug selection, including combination products to increase adherence.
Recommend conventional glaucoma therapy as well as other options in glaucoma management when indicated.
Formulate basic ophthalmologic monitoring parameters used in glaucoma therapy.
Counsel patients on medication regimens and proper ophthalmic administration technique.
Discuss potential adverse drug reactions with patients to increase therapy adherence.
“My vision is closing down and I am having difficulty seeing cars at intersections while driving.”
Macy Connor is a 75-year-old woman who presents for follow-up of advanced primary open-angle glaucoma (POAG). She reports adherence with latanoprost nightly and timolol/brimonidine (Combigan) two times daily in the right eye and dorzolamide three times daily in the left eye. She feels that her vision in the left eye is beginning to blur, and she is having more difficulty seeing objects in the top part of her vision. She finds that she has to move her head more to see objects in her periphery. She denies eye pain, flashes, or floaters. She is feeling more tired recently.
Mrs Connor was first diagnosed with POAG 20 years ago during a routine eye exam to update her eyeglass prescription. She had no visual disturbances at that time, and her best corrected vision was 20/20 OU. She was started on pilocarpine 1% three times daily in both eyes and developed brow ache and blurred vision. This was discontinued and she was started on timolol 0.5% twice daily in both eyes. Her highest IOP prior to treatment was 30 mm Hg, which improved to 25 mm Hg on timolol. Her eye pressure gradually increased requiring the addition of brimonidine three times daily and latanoprost nightly in both eyes. She underwent cataract surgery 2 years ago and experienced an IOP spike to 55 mm Hg and was given acetazolamide 250 mg PO four times daily for 5 days after surgery until her pressure improved. Three months after surgery, her IOP control had improved, and therapy in her left eye was changed to dorzolamide three times daily only.
Hypertension, well controlled on lisinopril for 6 years
Kidney stones (occurred while taking acetazolamide)
Migraine headaches; well controlled on sumatriptan with one to two migraines per year
Depression; controlled with exercise and counseling only; has never taken medications for depression